Anthony Bergmann | executive |
Linda Marbán | executive |
Kristen Kluska | analyst |
Edward Tenthoff | analyst |
Joseph Pantginis | analyst |
Aydin Huseynov | analyst |
Good afternoon, ladies and gentlemen, and welcome to the Capricor Therapeutics First Quarter 2024 Earnings Call. [Operator Instructions]
I would now like to turn the conference over to A.J. Bergmann. Please go ahead.